HealthDay - FRIDAY, Nov. 21 (HealthDay News) -- Banzel (rufinamide) has been approved by the U.S. Food and Drug government to treat seizures associated with Lennox-Gastaut syndrome, a severe form of epilepsy.
More: - Brought to my attention by
Name(required)
Mail (will not be published)(required)
Website
Notify me of followup comments via e-mail.